Matrix metalloproteinases at cancer tumor-host interface

Seminars in Cell and Developmental Biology

Volumn 19, Issue 1, 2008, Pages 52-60

  Noël, Agnès ^a   Jost, Maud ^a   Maquoi, Erik ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Angiogenesis; Cancer invasion; Inflammation; Stromal proteases

Indexed keywords

MATRIX METALLOPROTEINASE;

ADIPOCYTE; ANGIOGENESIS; CANCER; CANCER GROWTH; CANCER INVASION; ENDOTHELIUM CELL; HOST CELL; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; MAST CELL; METASTASIS; NEUTROPHIL; NONHUMAN; PERICYTE; REVIEW; TUMOR CELL;

EID: 36849080314     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2007.05.011     Document Type: Review

References (113)

1. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat Med 10 (2004) 789-799
2. Fidler I.J. The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat Rev Cancer 3 (2003) 453-458
3. Albini A., and Sporn M.B. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7 (2007) 139-147
4. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17 (2001) 463-516
5. Mueller M.M., and Fusenig N.E. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4 (2004) 839-849
6. Tlsty T.D., and Hein P.W. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 11 (2001) 54-59
7. Mareel M., and Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83 (2003) 337-376
8. Overall C.M., and Kleifeld O. Tumour microenvironment-opinion-validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6 (2006) 227-239
9. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2 (2002) 161-174
10. Overall C.M., and Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2 (2002) 657-672
11. Folgueras A.R., Pendas A.M., Sanchez L.M., and Lopez-Otin C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48 (2004) 411-424
12. Page-McCaw A., Ewald A.J., and Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8 (2007) 221-233
13. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92 (2003) 827-839
14. Brew K., Dinakarpandian D., and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477 (2000) 267-283
15. Murphy G., Knauper V., Lee M.H., Amour A., Worley J.R., Hutton M., et al. Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. Biochem Soc Symp 70 (2003) 65-80
16. Noel A., Maillard C., Rocks N., Jost M., Chabottaux V., Sounni N.E., et al. Membrane associated proteases and their inhibitors in tumour angiogenesis. J Clin Pathol 57 (2004) 577-584
17. Sounni N.E., and Noel A. Membrane type-matrix metalloproteinases and tumor progression. Biochimie 87 (2005) 329-342
18. Ii M., Yamamoto H., Adachi Y., Maruyama Y., and Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med 231 (2006) 20-27
19. Jost M., Folgueras A.R., Frerart F., Pendas A.M., Blacher S., Houard X., et al. Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient mice. Cancer Res 66 (2006) 5234-5241
20. Balbin M., Fueyo A., Tester A.M., Pendas A.M., Pitiot A.S., Astudillo A., et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 35 (2003) 252-257
21. Rio M.C. From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation. Biochimie 87 (2005) 299-306
22. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 (2003) 49-54
23. van't Veer L.J., Dai H.Y., van de Vijver M.J., He Y.D.D., Hart A.A.M., Mao M., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
24. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W.P., Giri D.D., et al. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
25. Gupta G.P., Nguyen D.X., Chiang A.C., Bos P.D., Kim J.Y., Nadal C., et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446 (2007) 765-770
26. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
27. Kaplan R.N., Rafii S., and Lyden D. Preparing the "Soil": the premetastatic niche. Cancer Res 66 (2006) 11089-11093
28. Hiratsuka S., Watanabe A., Aburatani H., and Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8 (2006) 1369-1375
29. Hiratsuka S., Nakamura K., Iwai S., Murakami M., Itoh T., Kijima H., et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2 (2002) 289-300
30. Skoog T., Ahokas K., Orsmark C., Jeskanen L., Isaka K., and Saarialho-Kere U. MMP-21 is expressed by macrophages and fibroblasts in vivo and in culture. Exp Dermatol 15 (2006) 775-783
31. Harrell P.C., McCawley L.J., Fingleton B., McIntyre J.O., and Matrisian L.M. Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells. Exp Cell Res 303 (2005) 308-320
32. Yu W.H., Woessner Jr. J.F., McNeish J.D., and Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 16 (2002) 307-323
33. Noe V., Fingleton B., Jacobs K., Crawford H.C., Vermeulen S., Steelant W., et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 114 (2001) 111-118
34. Powell W.C., Fingleton B., Wilson C.L., Boothby M., and Matrisian L.M. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 9 (1999) 1441-1447
35. Djonov V., Hogger K., Sedlacek R., Laissue J., and Draeger A. MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours. J Pathol 195 (2001) 147-155
36. Impola U., Toriseva M., Suomela S., Jeskanen L., Hieta N., Jahkola T., et al. Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. Int J Cancer 103 (2003) 709-716
37. Pendas A.M., Folgueras A.R., Llano E., Caterina J., Frerard F., Rodriguez F., et al. Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice. Mol Cell Biol 24 (2004) 5304-5313
38. Gilles C., Newgreen D.F., Sato H., and Thompson E.W. Matrix metalloproteases and epithelial-to-mesenchymal transition: implications for carcinoma metastasis. In: Savagner P. (Ed). Rise and Fall of Epithelial Phenotype (2004), Eurokah.com and Kluwer Academic/Plenum Publishers, New York 233-251
39. Lohi J., Wilson C.L., Roby J.D., and Parks W.C. Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem 276 (2001) 10134-10144
40. Illman S.A., Lehti K., Keski-Oja J., and Lohi J. Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells. J Cell Sci 119 (2006) 3856-3865
41. Friedl P., and Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3 (2003) 362-374
42. Hotary K., Li X.Y., Allen E., Stevens S.L., and Weiss S.J. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev 20 (2006) 2673-2686
43. Lambert V., Wielockx B., Munaut C., Galopin C., Jost M., Itoh T., et al. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J 17 (2003) 2290-2292
44. Masson V., de la Ballina L.R., Munaut C., Wielockx B., Jost M., Maillard C., et al. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J 18 (2005) 234
45. Chabottaux V., Sounni N.E., Pennington C.J., English W.R., van den Brule F., Blacher S., et al. Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Res 66 (2006) 5165-5172
46. Zigrino P., Loffek S., and Mauch C. Tumor-stroma interactions: their role in the control of tumor cell invasion. Biochimie 87 (2005) 321-328
47. Ala-Aho R., and Kahari V.M. Collagenases in cancer. Biochimie 87 (2005) 273-286
48. Bisson C., Blacher S., Polette M., Blanc J.F., Kebers F., Desreux J., et al. Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells. Int J Cancer 105 (2003) 7-13
49. Sternlicht M.D., Lochter A., Sympson C.J., Huey B., Rougler J.P., Gray J.W., et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98 (1999) 137-146
50. Basset P., Bellocq J.P., Wolf C., Stoll I., Hutin P., Limacher J.M., et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348 (1990) 699-704
51. Zucker S., Pei D., Cao J., and Lopez-Otin C. Membrane type-matrix metalloproteinases (MT-MMP). Curr Top Dev Biol 54 (2003) 1-74
52. Polette M., and Birembaut P. Membrane-type metalloproteinases in tumor invasion. Int J Biochem Cell Biol 30 (1998) 1195-1202
53. Brooks P.C., Stromblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85 (1996) 683-693
54. Johansson N., Vaalamo M., Grenman S., Hietanen S., Klemi P., Saarialho-Kere U., et al. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol 154 (1999) 469-480
55. Boulay A., Masson R., Chenard M.P., El Fahime M., Cassard L., Bellocq J.P., et al. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. Cancer Res 61 (2001) 2189-2193
56. Noel A., and Foidart J.M. The role of extracellular matrix and fibroblasts in breast carcinoma growth in vivo. J Mammary Gland Biol Neoplasia 3 (1998) 215-225
57. Noel A., Hajitou A., L'Hoir C., Maquoi E., Baramova E., Lewalle J.M., et al. Inhibition of stromal matrix metalloproteases: effects on breast-tumor promotion by fibroblasts. Int J Cancer 76 (1998) 267-273
58. Masson R., Lefebvre O., Noel A., El Fahime M., Chenard M.P., Wendling C., et al. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol 140 (1998) 1535-1541
59. Zhang W.Y., Matrisian L.M., Holmbeck K., Vick C.C., and Rosenthal E.L. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer 6 (2006)
60. Bavik C., Coleman I., Dean J.P., Knudsen B., Plymate S., and Nelson P.S. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res 66 (2006) 794-802
61. Liu D., and Hornsby P.J. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res 67 (2007) 3117-3126
62. Radisky D.C., Levy D.D., Littlepage L.E., Liu H., Nelson C.M., Fata J.E., et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436 (2005) 123-127
63. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4 (2004) 71-78
64. Mantovani A., Bottazzi B., Colotta F., Sozzani S., and Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 13 (1992) 265-270
65. Leek R.D., Lewis C.E., Whitehouse R., Greenall M., Clarke J., and Harris A.L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56 (1996) 4625-4629
66. Torisu H., Ono M., Kiryu H., Furue M., Ohmoto Y., Nakayama J., et al. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNF alpha and IL-1 alpha. Int J Cancer 85 (2000) 182-188
67. Lin E.Y., Nguyen A.V., Russell R.G., and Pollard J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193 (2001) 727-739
68. Robinson S.C., Scott K.A., and Balkwill F.R. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. Eur J Immunol 32 (2002) 404-412
69. Huang S.Y., Van Arsdall M., Tedjarati S., McCarty M., Wu W.J., Langley R., et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94 (2002) 1134-1142
70. Dong Z., Kumar R., Yang X., and Fidler I.J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88 (1997) 801-810
71. Cornelius L.A., Nehring L.C., Harding E., Bolanowski M., Welgus H.G., Kobayashi D.K., et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol 161 (1998) 6845-6852
72. Houghton A.M., Grisolano J.L., Baumann M.L., Kobayashi D.K., Hautamaki R.D., Nehring L.C., et al. Macrophage elastase (matrixmetalloproteinase-12) suppresses growth of lung metastases. Cancer Res 66 (2006) 6149-6155
73. Kankkunen J.P., HArvima I.T., and Naukkarinen A. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 72 (1997) 385-388
74. Duncan L.M., Richards L.A., and Mihm M.C. Increased mast cell density in invasive melanoma. J Cutan Pathol 25 (1998) 11-15
75. Roche W.R. The nature and significance of tumour-associated mast cells. J Pathol 148 (1986) 175-182
76. Coussens L.M., Raymond W.W., Bergers G., Laig-Webster M., Behrendtsen O., Werb Z., et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13 (1999) 1382-1397
77. Coussens L.M., Tinkle C.L., Hanahan D., and Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103 (2000) 481-490
78. Scott K.G. The mast cell, its amines, and tumor growth in rodents and man. Ann NY Acad Sci 103 (1963) 285-312
79. Fang K.C., Wolters P.J., Steinhoff M., Bidgol A., Blount J.L., and Caughey G.H. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. J Immunol 162 (1999) 5528-5535
80. Gruber B.L., Marchese M.J., Suzuki K., Schwartz L.B., Okada Y., Nagase H., et al. Synovial procollagenase activation by human mast-cell tryptase dependence upon matrix metalloproteinase-3 activation. J Clin Invest 84 (1989) 1657-1662
81. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2 (2000) 737-744
82. Van Lint P., and Libert C. Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev 17 (2006) 217-223
83. Tester AM, Cox JH, Connor AR, Starr AE, Dean RA, Puente XS et al. LPS Responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PLoS ONE 2007;March 2007:e312.
84. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 (2005) 932-936
85. Hamano Y., and Kalluri R. Tumstatin, the NC1 domain of alpha 3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth. Biochem Biophys Res Commun 333 (2005) 292-298
86. Ferreras M., Felbor U., Lenhard T., Olsen B.R., and Delaisse J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 486 (2000) 247-251
87. Yu Q., and Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14 (2000) 163-176
88. Van den Steen P.E., Proost P., Wuyts A., Van Damme J., and Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96 (2000) 2673-2681
89. McQuibban G.A., Butler G.S., Gong J.H., Bendall L., Power C., Clark-Lewis I., et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276 (2001) 43503-43508
90. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
91. Oh J., Takahashi R., Adachi E., Kondo S., Kuratomi S., Noma A., et al. Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice. Oncogene 23 (2004) 5041-5048
92. Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov S.A., et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99 (1999) 81-92
93. Zhou Z., Apte S.S., Soininen R., Cao R., Baaklini G.Y., Rauser R.W., et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci USA 97 (2000) 4052-4057
94. Handsley M.M., and Edwards D.R. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 115 (2005) 849-860
95. Chun T.-H., Sabeh F., Ota I., Murphy H., McDonagh K.T., Holmbeck K., et al. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol 167 (2004) 757-767
96. Hiraoka N., Allen E., Apel I.J., Gyetko M.R., and Weiss S.J. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95 (1998) 365-377
97. Plaisier M., Kapiteijn K., Koolwijk P., Fijten C., Hanemaaijer R., Grimbergen J.M., et al. Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3-MMP. J Clin Endocrinol Metab 89 (2004) 5828-5836
98. Davis G.E., and Saunders W.B. Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. J Invest Dermatol 11 (2006) 44-56
99. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109 (2002) 625-637
100. Chantrain C.F., Shimada H., Jodele S., Groshen S., Ye W., Shalinsky D.R., et al. Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Res 64 (2004) 1675-1686
101. Manes S., Mira E., Barbacid M.D., Cipres A., FernandezResa P., Buesa J.M., et al. Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J Biol Chem 272 (1997) 25706-25712
102. Sheu B.C., Hsu S.M., No H.N., Tien H.C., Huang S.C., and Lin R.B. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res 61 (2001) 237-242
103. Miyamoto S., Nakamura M., Yano K., Ishii G., Hasebe T., Endoh Y., et al. Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix. Cancer Sci 98 (2007) 685-691
104. Overall C.M., McQuibban G.A., and Clark-Lewis I. Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics. Biol Chem 383 (2002) 1059-1066
105. Iyengar P., Espina V., Williams T.W., Lin Y., Berry D., Jelicks L.A., et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest 115 (2005) 1163-1176
106. Mauro L., Catalano S., Bossi G., Pellegrino M., Barone I., Morales S., et al. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. Cancer Res 67 (2007) 3412-3421
107. Klein J., Permana P., Owecki M., Chaldakov G., Bohm M., Hausman G., et al. What are subcutaneous adipocytes really good for?. Exp Dermatol 16 (2007) 45-70
108. Maquoi E., Munaut C., Colige A., Collen D., and Lijnen H.R. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51 (2002) 1093-1101
109. Andarawewa K.L., Motrescu E.R., Chenard M.P., Gansmuller A., Stoll I., Tomasetto C., et al. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res 65 (2005) 10862-10871
110. Deryugina E.I., Ratnikov B.I., Postnova T.I., Rozanov D.V., and Strongin A.Y. Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem 277 (2002) 9749-9756
111. Koshikawa N., Giannelli G., Cirulli V., Miyazaki K., and Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 148 (2000) 615-624
112. Kajita M., Itoh Y., Chiba T., Mori H., Okada A., Kinoh H., et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153 (2001) 893-904
113. Belkin A.M., Akimov S.S., Zaritskaya L.S., Ratnikov B.I., Deryugina E.I., and Strongin A.Y. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem 276 (2001) 18415-18422